Breast cancer cdk 4/6 inhibition
This course is a collection of modules on breast cancer CDK 4/6 inhibition, developed to support the professional development of three distinct healthcare professions. The content is based on the presentations that were given during the Coming of Age for CDK 4/6 Inhibitors industry satellite symposium held at the ESMO 2016 conference in Copenhagen, Denmark. The objective of this satellite symposium was to establish and deliver a globally leading educational initiative that has a significant impact on clinical practice.
This module is suitable for oncologists interested in the latest developments and research in breast cancer.
Published August 2017.